Bionaut
Tuesday, June 04, 2024
Company Presentation
![CNS/Neurological](https://cdn.asp.events/CLIENT_BIO_7BB99CBA_BAD1_B8C8_CF9F25DA29A80CC6/sites/BIOIC-2024/media/icons/seminars/blank.png)
Company Presentation Theater 4
Bionaut: Revolutionizing CNS drug delivery.
Bionaut is a global biotechnology and drug delivery company dedicated to pioneering innovative solutions for brain-targeted therapies. Conventional drug delivery methods (infusion, intra-thecal) grapple with the blood-brain barrier, yielding low brain concentration, limited efficacy, and systemic side effects. Surgical options (ventricular catheters, CED) are invasive and have restricted reach. Our cutting-edge minimally invasive micro-robotic precision CNS drug delivery platform enables the accurate, safe, and effective administration of treatments to challenging brain & spine regions for a diverse range of therapeutics (small molecules, biologics, ASOs, AAVs, Gene Tx, Radiotherapy).
Backed by robust pre-clinical safety data and poised for upcoming 2024 clinical trials, Bionaut seeks to explore collaboration with pharma companies.
![Bionaut](https://www.abstractscorecard.com/uploads/Tasks/upload/21754/XDQDGWMO-1740131-1-JPG.png)
Company Website:
http://www.bionautlabs.com
Lead Product in Development:
Bionaut micro-robotic precision CNS drug delivery platform
Number Of Unlicensed Products (For Which You Are Seeking Partners):
1
Company HQ City
Los Angeles
Company HQ State
CA
Company HQ Country
United States
CEO/Top Company Official
Michael Shipelmacher
Development Phase of Primary Product
Phase I
Primary Speaker